Published in Virology on December 27, 2005
Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol (2007) 3.53
Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 2.63
Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol (2007) 2.23
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81
Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol (2007) 1.77
Dynamics of influenza virus infection and pathology. J Virol (2010) 1.62
Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol (2008) 1.62
NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol (2006) 1.35
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol (2009) 1.32
Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription. Virology (2010) 1.26
Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. J Virol (2010) 1.25
Early control of H5N1 influenza virus replication by the type I interferon response in mice. J Virol (2009) 1.24
Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol (2007) 1.14
Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol (2010) 1.13
The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol (2007) 1.13
A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One (2011) 1.07
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. J Infect Dis (2011) 1.04
Innate immune evasion strategies of influenza viruses. Future Microbiol (2010) 1.00
Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses. Virology (2008) 0.97
Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS One (2012) 0.97
Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. Virol J (2010) 0.95
Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One (2011) 0.92
Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells. PLoS One (2013) 0.92
Phylogenetic analysis of the non-structural (NS) gene of influenza A viruses isolated from mallards in Northern Europe in 2005. Virol J (2008) 0.91
A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol (2014) 0.90
Influenza virus activation of the interferon system. Virus Res (2015) 0.88
The influenza A virus protein NS1 displays structural polymorphism. J Virol (2014) 0.86
SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization. J Virol (2013) 0.85
Heterologous SH3-p85beta inhibits influenza A virus replication. Virol J (2010) 0.81
An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo. J Gen Virol (2012) 0.81
Avian influenza virus H5N1 induces rapid interferon-beta production but shows more potent inhibition to retinoic acid-inducible gene I expression than H1N1 in vitro. Virol J (2012) 0.80
Differences in the ability to suppress interferon β production between allele A and allele B NS1 proteins from H10 influenza A viruses. Virol J (2010) 0.80
Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome. PLoS One (2015) 0.79
Principles underlying rational design of live attenuated influenza vaccines. Clin Exp Vaccine Res (2012) 0.78
The non-structural (NS) gene segment of H9N2 influenza virus isolated from backyard poultry in Pakistan reveals strong genetic and functional similarities to the NS gene of highly pathogenic H5N1. Virulence (2013) 0.78
NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses. J Virol (2017) 0.77
Model of influenza A virus infection: dynamics of viral antagonism and innate immune response. J Theor Biol (2014) 0.77
NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses. J Virol (2016) 0.76
Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission tomography in vivo. Mol Imaging Biol (2013) 0.76
Changes in the NS1 gene of avian influenza viruses isolated in Thailand affect expression of type I interferon in primary chicken embryonic fibroblast cells. Indian J Virol (2013) 0.75
Gene expression patterns induced at different stages of rhinovirus infection in human alveolar epithelial cells. PLoS One (2017) 0.75
The sequence of the human genome. Science (2001) 101.55
Regulation of inducible and tissue-specific gene expression. Science (1987) 15.04
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A (2004) 7.51
Kidney transplantation under FK 506. JAMA (1990) 7.45
The human beta-interferon gene enhancer is under negative control. Cell (1986) 5.61
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol (1999) 4.99
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Human beta-interferon gene expression is regulated by an inducible enhancer element. Cell (1985) 4.68
Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J (1989) 4.10
Human 7SL RNA consists of a 140 nucleotide middle-repetitive sequence inserted in an alu sequence. Cell (1982) 3.74
Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics (1996) 3.59
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol (2000) 3.50
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18
Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology (2000) 2.67
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol (1999) 2.51
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
The beta-interferon promoter responds to priming through multiple independent regulatory elements. J Biol Chem (1994) 2.36
Proximal sequence element-binding transcription factor (PTF) is a multisubunit complex required for transcription of both RNA polymerase II- and RNA polymerase III-dependent small nuclear RNA genes. Mol Cell Biol (1995) 2.33
Characterization of influenza virus RNA complete transcripts. Virology (1982) 2.31
The 5' flanking region of human epsilon-globin gene. Nucleic Acids Res (1980) 2.30
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol (2012) 2.20
Sharing electronic medical records across multiple heterogeneous and competing institutions. Proc AMIA Annu Fall Symp (1996) 2.14
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
Maintaining patient access to GUM clinics: is it compatible with appointments? Sex Transm Infect (2003) 2.08
Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B. Nucleic Acids Res (1993) 2.08
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer (1973) 2.05
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med (2000) 2.03
Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol (1998) 1.99
Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene (2009) 1.99
Efficacy of combined antidepressant therapy in resistant neurotic disorder. Br J Psychiatry (1990) 1.97
Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol (2001) 1.95
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet (1990) 1.94
Effect of storage temperature on maintenance of platelet viability--deleterious effect of refrigerated storage. N Engl J Med (1969) 1.94
Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma. J Allergy Clin Immunol (2001) 1.89
Storage of platelet concentrates at 22 degrees C. Blood (1970) 1.86
The Benzodiazepine Withdrawal Symptom Questionnaire. J Affect Disord (1990) 1.85
Common mechanisms of promoter recognition by RNA polymerases II and III. Trends Genet (1989) 1.80
Influenza virus RNA segment 7 has the coding capacity for two polypeptides. Virology (1980) 1.80
The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol (2002) 1.74
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72
Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child (1997) 1.71
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2012) 1.67
STAT1 is inactivated by a caspase. J Biol Chem (1998) 1.67
Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res (1980) 1.61
HIV infection among sub-Saharan African patients in the UK. Lancet (1989) 1.59
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Induction of nitric oxide synthase in glial cells. J Neurochem (1992) 1.55
Age-related risk for HIV infection in men who have sex with men: examination of behavioral, relationship, and serostatus variables. AIDS Educ Prev (2000) 1.55
Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol (2008) 1.55
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood (1998) 1.54
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A (1999) 1.54
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol (1996) 1.54
The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet (1988) 1.53
Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr (1995) 1.53
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest (1978) 1.53
Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology (2002) 1.52
The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology (1994) 1.51
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol (1999) 1.51
Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol (2005) 1.50
The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population. Ann Trop Med Parasitol (1994) 1.49
Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother (1992) 1.49
Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Comparison with worldwide reports. Arch Pediatr Adolesc Med (1994) 1.49
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Risk factors of female HIV-seropositive patients attending the clinic for sexually transmitted diseases at St Mary's Hospital, London. Int J STD AIDS (1990) 1.46
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localisation. J Cell Sci (1993) 1.45
Treating sexually transmitted infections in primary care: a missed opportunity? Sex Transm Infect (2003) 1.45
Virus replication in engineered human cells that do not respond to interferons. J Virol (2003) 1.44
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Acid-base status of blood from intraosseous and mixed venous sites during prolonged cardiopulmonary resuscitation and drug infusions. Crit Care Med (1999) 1.44
Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res (2000) 1.44
Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome. Br J Obstet Gynaecol (1994) 1.43
Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Transfusion (1992) 1.43
Use of intraosseous blood to assess blood chemistries and hemoglobin during cardiopulmonary resuscitation with drug infusions. Crit Care Med (1999) 1.43
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood (1981) 1.40
The British Journal of Social Medicine: what was in a name? J Epidemiol Community Health (1997) 1.40
Enzymatic conversion of vitamin B 12a to adenosyl-B 12: evidence for the existence of two separate reducing systems. Arch Biochem Biophys (1969) 1.39
Using HL7 and the World Wide Web for unifying patient data from remote databases. Proc AMIA Annu Fall Symp (1996) 1.39
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J (2002) 1.38
Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am J Trop Med Hyg (1996) 1.38
Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, and laboratory findings. Radiology (1992) 1.38
DNA sequences complementary to human 7 SK RNA show structural similarities to the short mobile elements of the mammalian genome. J Mol Biol (1984) 1.37
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Interobserver variation in respiratory signs of severe malaria. Arch Dis Child (1995) 1.36
NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol (2006) 1.35
A sequence upstream from the coding region is required for the transcription of the 7SK RNA genes. Nucleic Acids Res (1986) 1.33
Comparison of the HOTV and Lea Symbols charts for preschool vision screening. J Pediatr Ophthalmol Strabismus (1997) 1.33